• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
  • New

Elsevier's 2026 Intravenous Medications

9780443269592
262.03 zł
222.73 zł Save 39.30 zł Tax included
Lowest price within 30 days before promotion: 222.73 zł
Quantity
Teaser
2025-04-01

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
For nearly 50 years, Elseviers Intravenous Medications:: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2026 edition are many new monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
Product Details
Elsevier
102833
9780443269592
9780443269592

Data sheet

Publication date
2025
Issue number
42
Cover
soft binded
Pages count
1360
Dimensions (mm)
152 x 229
  • General Dilution Charts (inside front cover and facing page) How to Use This Book Evolve Website Information Format and Content of Intravenous Medications Key to Abbreviations Important IV Therapy Facts Resources IV Drugs [alphabetical drug monographs] Back Matter Appendixes: A. Recommendations for the Safe Use and Handling of Cytotoxic Drugs B. FDA Pregnancy Categories C. U.S. Department of Health and Human Services, National Institutes of Health, and National Cancer Institute Common Terminology Criteria for Adverse Events D. Information for Patients Receiving Immunosuppressive Agents E. Recently Approved Drugs Index
Comments (0)